• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • FDA Approvals
  • New Paper Alert
  • Community
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Dec / 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Nov    
OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
  • Voices
  • FDA Approvals
  • New Paper Alert
  • Community
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

25 Posts Not to Miss from SABCS 2025

Events

European Commission Welcomes Political Agreement on Major Reform of EU Pharmaceutical Rules

Events

Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review

Bristol Myers Squibb

Stephen Miller's Message as Executive Director Upon Leaving Cedars-Sinai

Events

Hedley Lewis: A New Research Hub to Transform Paediatric Cancer Care in South Africa

Hedley Lewis

Maintenance Therapy After First-Line Therapy for Ovarian Cancer - ACS Journals

Events

Tinengotinib in Previously Treated Cholangiocarcinoma: New Signals from a Multicentre Phase 2 Trial

Tinengotinib for BTC

OncoCalendar

12 events found.

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
  • Summary
Today
  • December 2024

  • Thu 19
    Dec 19, 2024 • 4:00 PM - 5:00 PM

    LATAM Course II: Immunotherapy in Lung Cancer by IASLC

    LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th, 2024. The exclusive course on the latest updates in lung cancer treatment in LATAM, with a special focus on immunotherapy, will take place in Series II. Renowned thoracic oncology experts from the region will explore the role of immunotherapy in […]

  • Thu 19
    Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC
    Dec 19, 2024 • 6:00 PM - 7:00 PM

    Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC

    Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19, 2024. This live webinar will start with an introduction by Nadia Harbeck from Germany, setting the stage for the evening's discussions. Shani Paluch-Shimon from Israel will then present the latest updates on Early Breast Cancer (EBC) […]

  • Mon 30
    Dec 30, 2024 • 10:00 AM - 12:00 PM

    Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC

    Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC will be held at December 30, 2024. This Exclusive Virtual Course focuses on the latest updates in lung cancer treatment in Eastern Europe and the Balkan States, with a particular emphasis on immunotherapy. In Series I, leading thoracic oncology experts from the region […]

  • January 2025

  • Wed 15
    CACA
    Jan 15 • 2:00 PM - 4:00 PM

    2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents

    Virtual Event

    The Cancer Summit, organized by the China Anti-Cancer Association (CACA), OncoDaily, Sharing Progress in Cancer Care (SPCC), and the World Association for Integrative Oncology (WAIO), will take place on January 15, 2025 via Zoom and will feature simultaneous translation in English and Chinese. The summit will be held at the following times: China Standard Time: […]

  • Tue 21
    AACR
    Jan 21 • 1:00 PM - 2:30 PM

    Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR

    Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21, 2025, Virtually. The forum will explore the new generation of patient-centric cancer clinical trials, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer, […]

  • Thu 23
    BPDCN
    Jan 23

    International BPDCN Day

    WorldWide

    January 23rd of 2025 marks the International BPDCN Day. We unite to shed light on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare and aggressive hematologic malignancy that often remains underdiagnosed due to its rarity and complex presentation. What do we know about BPDCN? In 2008, BPDCN was recognized by the WHO as a distinct […]

  • Thu 23
    Immuno-oncology International Cancer Conference
    Jan 23 • 12:00 AM - Jan 24 • 12:00 AM

    The 17th BGICC 2025

    the Hilton Heliopolis Hotel in Cairo, Egypt El-Orouba, Sheraton Al Matar, El Nozha, Cairo Governorate, El Nozha, Cairo, Al, Egypt

    The 17th BGICC 2025 (Breast, Gynecological and Immuno-oncology International Cancer Conference) is a premier event in the field of oncology, widely recognized as the largest and most prestigious cancer conference in both Africa and the Middle East. Scheduled to take place from January 23-24, 2025, at the Hilton Heliopolis Hotel in Cairo, Egypt, this conference […]

  • Thu 23
    ASCO GI
    Jan 23 • 7:30 AM - Jan 25 • 4:00 PM

    ASCO Gastrointestinal Cancers Symposium 2025

    Moscone West 800 Howard Street, San Francisco, United States

    The ASCO Gastrointestinal Cancers 2025 Symposium, happening on January 23-25 in Moscone West, San Francisco, will bring together top experts in gastrointestinal oncology. Attendees can look forward to insightful keynote talks, engaging panel discussions, and the latest research on treatments and diagnostics for gastrointestinal cancers. The event will also showcase poster presentations from emerging researchers, […]

  • Thu 23
    HEAL
    Jan 23 • 3:00 PM - 5:00 PM

    HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances

    HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances will be held on 23 January 2024 at 15:00 CET. The HEAL Virtual Webinar Series on PFAS and Human Health is a crucial initiative aimed at raising awareness about the health impacts of PFAS (Per- and Polyfluoroalkyl Substances). These chemicals, widely used in […]

  • Fri 24
    The Breathe for Hope Conference
    Jan 24 • 8:00 AM - Jan 25 • 8:30 PM

    The Breathe for Hope Conference

    the Hilton Heliopolis Hotel in Cairo, Egypt El-Orouba, Sheraton Al Matar, El Nozha, Cairo Governorate, El Nozha, Cairo, Al, Egypt

    The Breathe for Hope Conference is a pioneering event that combines the expertise of the Oncothoracic International Cancer Association (OnTIC) and the Onco-Bronchology International Conference (OncoBroncho). Scheduled to take place on 24-25 January 2025 at the prestigious Hilton Cairo Heliopolis, this conference is designed to bring together leading professionals, researchers, and clinicians from across the […]

  • Sun 26
    Jan 26 • 6:00 PM - Jan 29 • 1:00 PM

    AACR Conference on Translating Targeted Therapies in Combination with Radiotherapy

    Hilton San Diego Bayfront 1 Park Blvd, San Diego, CA, United States

    The AACR Special Conference in Cancer Research: Translating Targeted Therapies in Combination with Radiotherapy, will be taking place at the Hilton San Diego Bayfront, on January 26-29, 2025. This conference will explore the future of radiation therapy, focusing on innovative areas like heavy ion therapy, FLASH radiation, and the synergy between radiation and targeted therapies. […]

  • Wed 29
    SPCC
    Jan 29 • 6:00 PM - 9:00 PM

    Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC

    Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th, 2025 at 6 pm. The Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: [email protected]

About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat

Oncology

OncoDaily

cancer

fight against cancer

Global fight against cancer

Breast Cancer

cancer care

ASCO

Lung cancer

Cancer research

ESMO

MD Anderson Cancer Center

Headlines

NSCLC

immunotherapy

cancer awareness

cancer treatment

Research

ASCO24

colorectal cancer

Childhood Cancer

prostate cancer

clinical trials

AACR

FDA

UICC

Dana-Farber Cancer Institute

American Cancer Society

European Cancer Organisation

SIOP

NCI

chemotherapy

National Cancer Institute

Vivek Subbiah

American Society of Clinical Oncology

healthcare

Myeloma

Robert Orlowski

Paolo Tarantino

Myeloma Paper of the Day

ASCO25

AI

IASLC

radiation oncology

WHO

Pancreatic Cancer

multiple myeloma

Memorial Sloan Kettering Cancer Center

cervical cancer

Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}